SCHEMBL3155741

SCHEMBL3155741

COc1ccc(CC2(O)CCN(CC(=O)Nc3cc(NCCNC(C)=O)nc(-c4ccccc4)n3)CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 11/20 0.48
▸ HTT P42858 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ POLB P06746 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ KDR P35968 1/20 0.43
▸ ESR1 P03372 1/20 0.42
▸ USP2 O75604 2/20 0.42
▸ TSHR P16473 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ CLK4 Q9HAZ1 1/20 0.41
▸ MTNR1A P48039 1/20 0.41
▸ MTNR1B P49286 1/20 0.41
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ GRIN2B Q13224 1/20 0.39
▸ CYP46A1 Q9Y6A2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3162879 0.93 UTS2R (0.44) ADORA3GRIN2BADORA2B
SCHEMBL3174273 0.92 TSHR (0.46) ADORA3HTTSMN1; SMN2POLBMAPK1
SCHEMBL3165120 0.91 UTS2R (0.39) ADORA3SMN1; SMN2USP2ADORA2B
SCHEMBL3162796 0.88 ADORA3 (0.53) ADORA3SMN1; SMN2KDRESR1USP2
SCHEMBL3165572 0.86 ALDH1A1 (0.42) ADORA3CYP2C19GRIN2BADORA2B
SCHEMBL3156575 0.85 ADORA3 (0.48) ADORA3HTTSMN1; SMN2ESR1TSHR
SCHEMBL3165286 0.85 USP2 (0.57) ADORA3HTTSMN1; SMN2POLBMAPK1
SCHEMBL3164888 0.83 ADORA3 (0.48) ADORA3SMN1; SMN2KDRESR1USP2
SCHEMBL3165134 0.83 ALDH1A1 (0.48) ADORA3HTTSMN1; SMN2POLBMAPK1
SCHEMBL3156070 0.82 TSHR (0.54) ADORA3HTTSMN1; SMN2USP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback